// App-Quantinova.ai

: Long Term Follow-up of a Phase 2 Study Examining Intratumoral G100 Alone and in Combination with Pembrolizumab in Patients with Follicular Lymphoma

Researchers

Presenter

  • Christopher R Flowers

Principal Investigators

  • Iris Isufi

  • Alex F. Herrera

  • Craig Okada

  • Elizabeth H. Cull

  • Bela Kis

  • Jorge M. Chaves

  • Nancy L. Bartlett

  • Weiyun Ai

  • Luis de la Cruz-Merino

  • Locke J. Bryan

  • Roch Houot

  • Kim Linton

  • Javier Briones

  • Ian Chau

  • Gottfried R. von Keudell

  • Hailing Lu

  • Frank J Hsu

  • Ahmad S Halwani

Medical Centers

  • Department of Epidemiology, Emory University, Atlanta, GA

  • Clinica Universidad de Navarra, Pamplona, Spain

  • Yale University, New Haven, CT

  • Department of Hematology and Hematopietic Cell Transplantation, City of Hope, Duarte, CA

  • Oregon Health and Science University, Portland, OR

  • GHS Cancer Institute, Greenville, SC

  • Moffitt Cancer Center, Tampa, FL

  • Northwest Medical Specialists PLLC, Tacoma, WA

  • Division of Oncology, Washington University School of Medicine, St. Louis, MO

  • Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA

  • Hospital Universitario Virgen del Rocio, Sevilla, Spain

  • Augusta University, Augusta, GA

  • Hematology Department, CHU de Reims, Reims, France

  • The Christie NHS Foundation TRUST, Manchester, United Kingdom

  • Oncology Department, Hospital de la Santa Creu i Sant Pau and Universitat Autonoma de Barcelona, Barcelona, Spain

  • GI and Lymphoma Unit, The Royal Marsden NHS Foundation Trust, London, United Kingdom

  • Yale University School of Medicine, New Haven, CT

  • Immune Design, Seattle, WA

  • Immune Design, South San Francisco, CA

  • Hunstman Cancer Institute of Utah, Salt Lake City, UT

Locations

  • United States

  • Spain

  • France

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Follicular lymphoma

Biomarkers

  • N/A

Drug/Treatment

  • Pembrolizumab

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved